CoChat

Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis

Open access
Yilmaz, H., Çelik, H.T., Gurel, O.M., Bilgic, M.A., Namuslu, M., Bozkurt, H., Ayyildiz, A., Inan, O., Bavbek, N., Akcay, A. · 2015 · Herz
Cited by 35

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background/aimsIncreased carotid intima–media thickness (CIMT) was shown to be an independent predictor of cardiovascular (CV) mortality in dialysis patients and the general population. Growth differentiation factor 15 (GDF-15), a member of the transforming growth factor superfamily, is produced by cardiomyocytes and atherosclerotic lesions under stress conditions such as inflammation. We assessed associations between serum concentrations of GDF-15, mortality, and CIMT for subclinical atherosclerosis in hemodialysis (HD) patients.MethodsA total of 87 patients on maintenance hemodialysis and 45 sex- and age-matched healthy controls were included in this prospective study. Serum GDF-15 levels were measured by ELISA. CIMT was assessed by Doppler ultrasonography. The association between serum GDF-15 levels and mortality was assessed using Cox regression analysis with serum levels categorized into two groups according to the median value (328.18 pg/ml). Patients were followed for 2 years and cause-specific and all-cause mortality were determined.ResultsThe median level of serum GDF-15 was significantly higher in HD patients than controls [328 (198–522) vs. 176 (101–289) pg/ml, p < 0.01, respectively]. Serum GDF-15 levels were correlated to CIMT (r = 0.607, p < 0.001), C-reactive protein (CRP; r = 0.250, p = 0.010), HD duration (r = 0.376, p = 0.004), and serum albumin (r = − 0.156, p = 0.030). The multivariate analysis revealed that GDF-15 was found to be an independent variable of CIMT in HD patients. In the study, the serum GDF-15 level was an independent marker of all-cause of mortality when adjusted for age, CRP, and history of diabetes mellitus.ConclusionThe relationship between serum GDF-15, mortality, and carotid artery thickening suggests that GDF-15 may be a novel marker of atherosclerosis, inflammation, and malnutrition in HD patients.ZusammenfassungHintergrund/ZieleEine erhöhte Intima-Media-Dicke der A. carotis (CIMT) ist nachgewiesen als unabhängiger Prädiktor der kardiovaskulären Mortalität, sowohl bei Hämodialyse(HD-)Patienten als auch der Allgemeinbevölkerung. Der Wachstumsdifferenzierungsfaktor 15 (GDF-15) aus der TGF(„transforming growth factors“)-Superfamilie wird von Kardiomyozyten und in atherosklerotischen Läsionen unter Stressbedingungen gebildet, z. B. bei Inflammation. Bestimmt wurden Assoziationen zwischen GDF-15-Serumkonzentrationen, Mortalität und CIMT für eine subklinische Atherosklerose bei Hämodialysepatienten.MethodenInsgesamt wurden 87 Dauer-HD-Patienten und 45 geschlechts- und altersgematchte Kontrollprobanden in die prospektive Studie aufgenommen. Die GDF-15-Serumkonzentrationen wurden per ELISA bestimmt, die CIMT mit Dopplersonographie. Assoziationen zwischen Serum-GDF-15-Konzentrationen und Mortalität wurden überprüft mittels Cox-Regressionsanalyse. Ausgehend vom Median (328,18 pg/ml) wurden 2 Gruppen gebildet. Die Follow-up-Phase war 2 Jahre lang, ermittelt wurden krankheitsspezifische wie generelle Mortalität.ErgebnisseDie mediane Konzentration von GDF-15 im Serum war bei HD-Patienten im Vergleich mit den Kontrollen signifikant höher [328 (198–522) vs. 176 (101–289) pg/ml, p < 0,01]. Korreliert mit Serum-GDF-15-Konzentrationen wurden C-reaktives Protein (CRP; r = 0,250, p = 0,010), Dauer der Dialyse (r = 0,376, p = 0,004) und Albuminkonzentration im Serum (r = − 0,156, p = 0,030). In der multivariaten Analyse erwies sich GDF-15 als eine unabhängige Variable für CIMT bei HD-Patienten. Ferner war die Serum-GDF-15-Konzentrationen nach Adjustierung für Alter, CRP und Diabetes-mellitus-Anamnese ein unabhängiger Marker für Mortalität allgemein.FazitDie Beziehung zwischen GDF-15-Serumkonzentrationen, Mortalität und erhöhter CIMT weist darauf hin, dass GDF-15 ein innovativer Marker für Atherosklerose, Inflammation und Mangelernährung bei HD-Patienten sein könnte.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00059-014-4139-5

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 35

Metadata

Authors
Yilmaz, H., Çelik, H. T., Gurel, O. M., Bilgic, M. A., Namuslu, M., Bozkurt, H., Ayyildiz, A., Inan, O., Bavbek, N., & Akcay, A.
Venue
Herz
Published
2014-08-14
Volume
40
Issue
S3
Pages
305-312
ISSN
  • 0340-9937 (ISSN-L)
  • 1615-6692
OpenAlex
W69092498
Cited by
35
References
5
FWCI
2.17
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis. https://app.cochat.ai/papers/10.1007/s00059-014-4139-5
The paper
Yilmaz, H., Çelik, H. T., Gurel, O. M., Bilgic, M. A., Namuslu, M., Bozkurt, H., Ayyildiz, A., Inan, O., Bavbek, N., & Akcay, A. (2015). Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis. Herz. https://doi.org/10.1007/s00059-014-4139-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.